The below Parliamentary question was asked by Andrew Gwynne on 2016-05-18.
To ask the Secretary of State for Health, how many times the Mental Capacity Act 2005 has been found to have been wrongly applied to exclude a relative of a resident from visiting a care home.
Alistair Burt
The information requested is not collected centrally.
The below Parliamentary question was asked by Andrew Gwynne on 2016-05-24.
To ask the Secretary of State for Health, what recent guidance his Department published to commissioners on meeting excess treatment costs for clinical trials.
George Freeman
In November 2015, NHS England published new guidance to help clarify the rules and expectations on the funding of excess treatment costs incurred during a non-commercial research study. The guidance is provided for clinical commissioning groups and commissioners of specialised services.
The below Parliamentary question was asked by Andrew Gwynne on 2016-06-06.
To ask the Secretary of State for Foreign and Commonwealth Affairs, how much his Department and its executive agencies spent on the publications (a) Who’s Who, (b) Burke’s Peerage and (c) Debrett’s in each year since 2010.
Mr David Lidington
This information is not recorded centrally and could only be provided at disproportionate cost.
The below Parliamentary question was asked by Andrew Gwynne on 2016-06-24.
To ask the Secretary of State for Health, if he will take steps to raise public awareness of the calorie content of alcoholic drinks; and if he will make a statement.
Jane Ellison
The last Government’s “Healthy Lives, Healthy People: A call to action on obesity in England”, October 2011 states that alcoholic drinks can be high in calories and contribute to the energy imbalance that can lead to being overweight and obesity.
We welcome the fact that some businesses are choosing to label calories voluntarily on their alcoholic beverages.
The below Parliamentary question was asked by Andrew Gwynne on 2016-09-12.
To ask the Secretary of State for Business, Energy and Industrial Strategy, what estimate he has made of the number of (a) Japanese, (b) American and (c) European pharmaceutical companies based in the UK; and how much those companies have invested in the UK in each of the last five years.
Joseph Johnson
There is no comprehensive data on the country of registration for the Global Ultimate Owner (GUO) of every company active in the UK pharmaceuticals sector.
We have incomplete data and therefore cannot accurately calculate how much these companies have invested in the UK in each of the last five years.
The below Parliamentary question was asked by Andrew Gwynne on 2016-09-15.
To ask the Secretary of State for Health, for how long it is planned that Commissioning through Evaluation will be in the assessment phase.
David Mowat
The analysis phase for a treatment entered in to Commissioning through Evaluation will vary in length as the time needed depends on the follow up evaluation measures that have been agreed by clinicians and patients at the start of each scheme.
The below Parliamentary question was asked by Andrew Gwynne on 2016-10-18.
To ask the Secretary of State for Foreign and Commonwealth Affairs, what discussions he has held with his counterparts in Qatar on the human rights situation and working conditions for foreign workers building stadia for the 2022 World Cup.
Mr Tobias Ellwood
We continue to support Qatar’s efforts in preparing for the FIFA World Cup in 2022, including ensuring UK businesses involved adhere to international and Qatari labour laws, and we support the steps that the Qatari government has taken to respond to concerns about the treatment of migrant workers. We continue to discuss implementation with the Qatari government and we welcome the Government of Qatar’s commitment to the ongoing, systematic reform of Qatar’s labour laws.
The below Parliamentary question was asked by Andrew Gwynne on 2015-11-02.
To ask Mr Chancellor of the Exchequer, what estimate he has made of the value of stationery that has been (a) lost and (b) stolen from his Department in each of the last five fiscal years; and what the cost was of replacing such stationery.
Harriett Baldwin
The information requested is not available.
The below Parliamentary question was asked by Andrew Gwynne on 2015-11-02.
To ask the Secretary of State for Work and Pensions, what estimate he has made of the value of stationery that has been (a) lost and (b) stolen from his Department in each of the last five fiscal years; and what the cost was of replacing such stationery.
Justin Tomlinson
This information is not available, as there is no central record kept of lost or stolen stationery.
The below Parliamentary question was asked by Andrew Gwynne on 2015-11-24.
To ask the Secretary of State for Health, what formal mechanism exists for sharing information between the Accelerated Access Review and Lord Carter’s review of NHS efficiency.
George Freeman
The Accelerated Access Review (AAR), chaired by Sir Hugh Taylor, will make recommendations to government on reforms to accelerate access for National Health Service patients to innovative medicines and medical technologies making our country the best place in the world to design, develop and deploy these products. The terms of the reference for the review focus on faster access to innovations, which may include certain off-patent repurposed drugs, as opposed to the routine availability of medicines or medical technologies.
Prior to establishing the terms of reference for the AAR, the Department reviewed evaluation reports and met with officials from previous initiatives on the uptake of innovation in the NHS including the Innovation, Health and Wealth report. As a result, building upon the lessons of previous reviews is explicit with the terms of reference of the AAR.
The AAR has regular meetings with senior officials from NHS England via a steering group as recommendations are being developed. In addition, some staff from NHS England have been assigned to support the review team.
Sir Hugh is still in the process of developing final recommendations which will be published in spring 2016. In his Interim Report published in October, Sir Hugh sets out a proposition on “galvanising the NHS”. This involves supporting the NHS to adopt innovation, more rapidly through better practical support, stronger incentives and the potential streamlining of local structures.
The Department reviewed evaluation reports and met with officials from previous initiatives on the uptake of innovation in the NHS prior to establishing the terms of reference for the AAR. It was clear that whilst progress has been made on the uptake of innovation in the NHS there is still much to do. Sir Hugh and the head of the External Advisory Group, Professor Sir John Bell, set out the case for uptake of innovation in the recently published AAR Interim Report.
The AAR has senior level contact with officials working on Lord Carter’s review of NHS efficiency to ensure that information is shared between the two teams.